A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Patients With Rheumatoid Arthritis
Clinical trial NCT01636557 · COMPLETED
Trial details
- NCT number
- NCT01636557
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-11
- Primary completion
- 2013-10-19
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.